Literature DB >> 15742190

Ten-year results of uncemented hip stems for failed intertrochanteric osteotomy.

Steffen J Breusch1, Martin Lukoschek, Marc Thomsen, Hans Mau, Volker Ewerbeck, Peter R Aldinger.   

Abstract

INTRODUCTION: Inferior survival of cemented total hip arthroplasty has been reported after previous femoral osteotomy. The purpose of this study was to evaluate the long-term survival of uncemented stems after femoral osteotomy.
MATERIALS AND METHODS: Forty-eight hips in 45 patients had undergone conversion THA for a failed intertrochanteric osteotomy of the hip after a mean of 12 years (2-33 years). Mean time of follow-up was 11 years (5-15 years).
RESULTS: At follow-up, two patients (three hips) had died, and one patient (one hip) was not located. Three patients (three hips) underwent femoral revision-one for infection and two for aseptic loosening of the stem. Survival of the stem was 94% at 10 years, and survival with femoral revision for aseptic loosening as an end point was 96%. The median Harris Hip Score at follow-up was 80 points. Radiolucent lines in Gruen zones 1 and 7 were present in 14 and 18% of hips, respectively. Radiolucencies in other zones were not detected. There was no radiographic evidence of femoral osteolysis, stress-shielding or loosening.
CONCLUSION: The results with this type of uncemented tapered titanium femoral component after proximal femoral osteotomy are encouraging and compare to those achieved in patients with regular femoral anatomy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15742190     DOI: 10.1007/s00402-005-0800-z

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  9 in total

Review 1.  [Hip arthroplasty in the presence of proximal femoral deformity].

Authors:  A Rakow; P Simon; C Perka
Journal:  Orthopade       Date:  2015-07       Impact factor: 1.087

Review 2.  Valgus intertrochanteric osteotomy for femur neck pseudoarthrosis: a simple solution to a complex problem that has stood the test of time.

Authors:  Ashok S Gavaskar; Parthasarathy Srinivasan; Balamurugan Jeyakumar; Rufus V Raj
Journal:  Int Orthop       Date:  2019-06-14       Impact factor: 3.075

3.  Long-term results of cementless femoral reconstruction following intertrochanteric osteotomy.

Authors:  Christian Merle; Marcus R Streit; Moritz Innmann; Tobias Gotterbarm; Peter R Aldinger
Journal:  Int Orthop       Date:  2012-01-12       Impact factor: 3.075

4.  Cementless total hip arthroplasty for patients previously treated with femoral osteotomy for hip dysplasia: the incidence of periprosthetic fracture.

Authors:  Masanobu Ohishi; Yasuharu Nakashima; Takuaki Yamamoto; Goro Motomura; Jun-Ichi Fukushi; Satoshi Hamai; Yusuke Kohno; Yukihide Iwamoto
Journal:  Int Orthop       Date:  2015-09-19       Impact factor: 3.075

Review 5.  Valgus osteotomy for nonunion and neglected neck of femur fractures.

Authors:  Viju Daniel Varghese; Abel Livingston; P R Boopalan; Thilak S Jepegnanam
Journal:  World J Orthop       Date:  2016-05-18

Review 6.  Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.

Authors:  Thomas G Koch; Lise C Berg; Dean H Betts
Journal:  Can Vet J       Date:  2009-02       Impact factor: 1.008

Review 7.  [Long-term results of uncemented stems in total hip arthroplasty: analysis of survival rates with a minimum 15-year follow-up].

Authors:  C Merle; M Clarius; P R Aldinger
Journal:  Orthopade       Date:  2010-01       Impact factor: 1.087

8.  Cemented allograft-prosthesis composite reconstruction for the proximal femur tumor.

Authors:  Li Min; Fan Tang; Hong Duan; Yong Zhou; Wen-Li Zhang; Rui Shi; Chong-Qi Tu
Journal:  Onco Targets Ther       Date:  2015-08-25       Impact factor: 4.147

9.  Uncemented allograft-prosthetic composite reconstruction of the proximal femur.

Authors:  Li Min; Jing Peng; Hong Duan; Wenli Zhang; Yong Zhou; Chongqi Tu
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.